Article Information
History
- January 7, 2022.
Article Versions
- Version 1 (December 11, 2021 - 11:13).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Nicolas Tessandier1,2,*,
- Ilkay Başak Uysal2,#,
- Baptiste Elie2,#,
- Christian Selinger2,
- Claire Bernat2,
- Vanina Boué2,
- Sophie Grasset2,
- Soraya Groc2,
- Tsukushi Kamiya1,3,
- Massilva Rahmoun2,
- Bastien Reyné2,
- Noemi Bender4,
- Marine Bonneau5,
- Christelle Graf5,
- Vincent Tribout6,
- Vincent Foulongne7,
- Jacques Ravel8,
- Tim Waterboer4,
- Christophe Hirtz9,
- Ignacio G Bravo2,
- Jacques Reynes10,
- Michel Segondy11,
- Carmen Lia Murall2,12,
- Nathalie Boulle13 and
- Samuel Alizon1,2,*
- 1Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France
- 2Laboratoire MIVEGEC (UMR CNRS 5290, IRD 224, UM), Montpellier, France
- 3HRB Clinical Research Facility, National University of Ireland Galway, Ireland
- 4Molecular Diagnostics of Oncogenic Infections, Infection, Inflammation and Cancer Program, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany
- 5Department of Obstetrics and Gynaecology, Centre Hospitalier Universitaire de Montpellier, Montpellier, France
- 6Center for Free Information, Screening and Diagnosis (CeGIDD), Centre Hospitalier Universitaire de Montpellier, Montpellier, France
- 7Pathogenesis and Control of Chronic Infections, Montpellier University, INSERM, EFS, Montpellier, France
- 8Institute for Genome Sciences, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA
- 9LBPC/PPC- IRMB, CHU de Montpellier and Université de Montpellier, Montpellier, France
- 10Infectious Diseases Departement, University Hospital Montpellier; INSERM U1175/Institut de Recherche et de Developement, Unité Mixte International, Montpellier, France
- 11Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, CHU Montpellier, Montpellier, France
- 12Department of Biological Sciences, Université de Montréal, Montréal, Canada
- 13Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; Departement of Pathology and Oncobiology, Laboratory of Solid Tumors, CHU Montpellier, Montpellier, France
- ↵*Corresponding authors: nicolas.tessandier{at}college-de-france.fr, samuel.alizon{at}cnrs.fr, Collège de France, 11 place Marcelin Berthelot, 75005 Paris, France, phone: +33 144271667
↵# Equal contribution